Using APP/PS1 mice to model human AD pathophysiology, in the present study we test the hypothesis that amyloid plaque reduction and cognitive improvement mediated by geniposide are correlated to mTOR inhibition and enhanced autophagy. This evidence concerns the gene APP and Alzheimer disease.